Clinical Trials Browser

Malignant mesenchymal tumor, Adenocarcinoma, Brenner Tumor, Carcinoma, Renal Cell, Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Hemangiopericytoma, Hemangiosarcoma, Leiomyosarcoma, Leukemia, Mast-Cell, Liposarcoma, Mastocytosis, Melanoma, Mesothelioma, Multiple Myeloma, Pleural Neoplasms, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Thymoma, Hypereosinophilic Syndrome, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Rhabdomyosarcoma, Embryonal, Seminoma, Carcinoma, Ductal, Breast, Neurofibrosarcoma, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT00589290 2015-09-30

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Phase 2 Completed

41 enrolled 8 charts

Thoracic

Mediastinal Neoplasms, Thymoma

NCT00387868 2014-12-09

Preoperative Treatment of Patients With High Risk Thymoma

Phase 2 Completed

21 enrolled

Thoracic

Thymoma

NCT00369889 2014-06-03

A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Phase 2 Completed

18 enrolled

Thoracic

Thymoma, Thymus Neoplasms

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Phase 2 Terminated

39 enrolled

Thoracic

Thymic epithelial tumor, Thymoma

NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Phase 2 Completed

90 enrolled

Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Clinical Trials

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

HEARTS Trial for Thoracic Cancers

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

IMMUNORARE5

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

RELEVENT

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Artemis

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

SELECT

RESOUND

Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma

A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

KOSMIC

TET-SEL

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Preoperative Treatment of Patients With High Risk Thymoma

A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Paclitaxel and Cisplatin for Thymic Neoplasm

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases